Polyinosinic acid has been reported to induce necrosis in cervical cancer cells through RIPK3 expression, suggesting that the ubiquitin–proteasome system may regulate RIPK3-dependent necroptosis and that targeting this pathway with proteasome inhibitors may be a potential strategy for anti-tumor drug development40. Here, RIPK3 is linked to cervical cancer.